These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2255588)

  • 1. Quantitative determination of particulate contamination in intravenous administration sets.
    Di Paolo ER; Hirschi B; Pannatier A
    Pharm Weekbl Sci; 1990 Oct; 12(5):190-5. PubMed ID: 2255588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of official instrumental methods for the determination of particulate matter contamination in large volume parenteral solutions.
    Montanari L; Pavanetto F; Conti B; Ponci R; Grassi M
    J Pharm Pharmacol; 1986 Nov; 38(11):785-90. PubMed ID: 2879006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Filtering effectiveness of conventional 15 m micron filters (DIN 58362) and newly developed 15 m micron and 5 m micron filters. I: Particle count].
    Walpot H; Franke RP; Burchard WG; Agternkamp C; Müller FG; Mittermayer C; Kalff G
    Infusionstherapie; 1989 Apr; 16(2):77-80. PubMed ID: 2737765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Particulate contaminants of intravenous medications and infusions.
    Backhouse CM; Ball PR; Booth S; Kelshaw MA; Potter SR; McCollum CN
    J Pharm Pharmacol; 1987 Apr; 39(4):241-5. PubMed ID: 2884285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Particulate matter test in small volume parenterals: critical aspects in sampling methodology.
    Pavanetto F; Conti B; Genta I; Ponci R; Montanari L; Grassi M
    Farmaco; 1989 Jun; 44(6):633-43. PubMed ID: 2803449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Particulate matter determination in LVPs produced in Dutch hospital pharmacies. Part 2: Overview of the results.
    Boom FA; Van der Veen J; Verbrugge P; Van de Vaart FJ; Paalman AC; Vos T
    PDA J Pharm Sci Technol; 2000; 54(4):343-58. PubMed ID: 10969531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particulate-matter content of 11 cephalosporin injections: conformance with USP limits.
    Parkins DA; Taylor AJ
    Am J Hosp Pharm; 1987 May; 44(5):1111-8. PubMed ID: 3605122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particles in small volume injections.
    Taylor SA; Spence J
    J Pharm Pharmacol; 1983 Dec; 35(12):769-73. PubMed ID: 6141237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro analysis of overall particulate contamination exposure during multidrug IV therapy: impact of infusion sets.
    Perez M; Décaudin B; Abou Chahla W; Nelken B; Barthélémy C; Lebuffe G; Odou P
    Pediatr Blood Cancer; 2015 Jun; 62(6):1042-7. PubMed ID: 25755136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Particulate contamination in selected parenteral drugs.
    Longe RL
    Can Anaesth Soc J; 1980 Jan; 27(1):62-4. PubMed ID: 7353193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleanliness assessment of supplier-cleaned stoppers.
    Townsend MW; Conti B; Hazrati A; DeLuca PP
    J Parenter Sci Technol; 1989; 43(2):98-102. PubMed ID: 2709242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of 72- versus 24-hour intravenous tubing set changes in newborns receiving lipid therapy.
    Matlow AG; Kitai I; Kirpalani H; Chapman NH; Corey M; Perlman M; Pencharz P; Jewell S; Phillips-Gordon C; Summerbell R; Ford-Jones EL
    Infect Control Hosp Epidemiol; 1999 Jul; 20(7):487-93. PubMed ID: 10432161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of particulate contamination in ampoules using a light blockage particle analyser.
    Alexander DM; Veltman AM
    J Pharm Pharmacol; 1985 Jan; 37(1):13-6. PubMed ID: 2858521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Particulate evaluation of parenteral nutrition solutions by electronic particle counting and scanning electron microscopy.
    Akers MJ; Schrank GD; Russell S
    Am J Hosp Pharm; 1981 Sep; 38(9):1304-7. PubMed ID: 6792911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particulate and microbial contamination in in-use admixed intravenous infusions.
    Yorioka K; Oie S; Oomaki M; Imamura A; Kamiya A
    Biol Pharm Bull; 2006 Nov; 29(11):2321-3. PubMed ID: 17077539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Particulate and microbial contamination in in-use admixed parenteral nutrition solutions.
    Oie S; Kamiya A
    Biol Pharm Bull; 2005 Dec; 28(12):2268-70. PubMed ID: 16327163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of particulate matter in small volume antibiotic injections].
    Niizeki M; Tanno K
    Jpn J Antibiot; 1989 Mar; 42(3):567-72. PubMed ID: 2746842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals. 72 hours is safe and cost-effective.
    Maki DG; Botticelli JT; LeRoy ML; Thielke TS
    JAMA; 1987 Oct; 258(13):1777-81. PubMed ID: 3114506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Particulate and microbial contamination of intraocular irrigation solutions.
    Neumann AC
    J Cataract Refract Surg; 1986 Sep; 12(5):485-8. PubMed ID: 3772782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lost bits: particle shedding with polyvinyl chloride intravenous administration sets.
    Subramanian P; Ainsworth P; Cassey J; Phelan D
    Pediatr Surg Int; 2002 Dec; 18(8):658-61. PubMed ID: 12598958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.